MCPHS University and Takeda Pharmaceuticals are pleased to offer Post PharmD Fellowship positions and are currently screening and scheduling interviews.
GLOBAL PHARMACOVIGILANCE (GPV)
With a mission to Ensure Patient Safety, the Global Patient Safety Evaluation (GPSE) function at Takeda is responsible for pharmacovigilance (PV) activities including the detection, assessment, management, monitoring, prevention of adverse event s and continuous assessment the benefit-risk profile for all Takeda products.
Excellence in Patient Safety requires mastery of medical and scientific disciplines as well as operational excellence and compliance. The purpose of Takeda’s two-year fellowship program is to provide the Fellow with in-depth training in safety risk assessment, characterization, and minimization/mitigation. Fellows work closely with experts in Pharmacovigilance, specifically with PV Scientists and Global Safety Leads, as well as with other GPSE colleagues and cross-functional groups across Takeda’s Therapeutic Areas. Fellows are dedicated to PV activities for both investigational and marketed products during the course of the fellowship. The goal of this program is to provide the Fellow with relevant experiences, technical skills, and development opportunities to become an effective expert in the area of Pharmacovigilance.
During this two-year fellowship program, the fellow will:
Participate and engage in cross-functional team meetings involving Clinical Sciences, Medical Affairs, Regulatory Affairs, Analytical Sciences, and more
Perform research to support risk management strategies and decisions
Prepare and review safety sections of periodic safety update reports, risk management plans, clinical trial protocols, investigator brochures, informed consent forms, and reference safety information for investigational or marketed products
Assist in the preparation and presentation of signal evaluation s
Follow regulations closely and communicate findings with relevant internal stakeholders
Contribute to GPSE external initiatives
Lead other pharmacovigilance related activities as instructed
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS Fluid Review application portal. Visit https://mcphs.fluidreview.com/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via PPS to schedule interviews.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal prior to November 26, 2018:
Letter of intent
Unofficial college transcript
Contact information of three references for letters of recommendation.
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
After ASHP Midyear Clinical Meeting
The three letters of recommendation must be submitted by the three provided contacts no later than December 10th
Top candidates will be invited for onsite interviews at the sponsoring company’s location. Final candidates will be required to go through additional screening / onboarding as required by MCPHS University
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Additional Salary Information: Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
About MCPHS University/Takeda
Takeda is a global pharmaceutical company founded in 1781 with headquarters in Osaka, Japan, and operations in more than 70 countries and regions worldwide, representing Japan, the United States, Europe, Latin America, Africa, the Middle East, and the Asia Pacific Region. Takeda's pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners). The company has grown in size and scope both organically and through acquisition.
BACK TO TOP
Primary references are publications that are cited as references during examination development.